Author

Shazi Shakil

Professor, King Abdulaziz University, Jeddah, Saudi Arabia - Cited by 5,030 - Medicinal Research - Protein ligand Docking - Antibiotic Discovery - Infectious Disease Research - Pharmaceutical Drug Design

Biography

Shazi Shakil, Department of Bio-engineering, Integral University, Lucknow-226026, India, published an article on A Region-specific Treatment Strategy To Address The Problem Of Drug Resistance By NDM-1-producing Pathogens.
Title
Cited by
Year
Silver nanoparticles from leaf extract of Mentha piperita: eco-friendly synthesis and effect on acetylcholinesterase activity
A Khatoon, F Khan, N Ahmad, S Shaikh, SMD Rizvi, S Shakil, ...Life sciences 209, 430-434, 2018201
81
2018
63
2015
Forxiga (dapagliflozin): Plausible role in the treatment of diabetes‐associated neurological disorders
S Shaikh, SMD Rizvi, S Shakil, S Riyaz, D Biswas, R JahanBiotechnology and applied biochemistry 63 (1), 145-150, 2016201
54
2016
Mutagenic, antioxidant and wound healing properties of Aloe vera
ACL de Oliveira, S Tabrez, S Shakil, MI Khan, MN Asghar, BD Matias, ...Journal of ethnopharmacology 227, 191-197, 2018201
46
2018
Synthesis and Characterization of Cefotaxime Conjugated Gold Nanoparticles and Their Use to Target Drug‐Resistant CTX‐M‐Producing Bacterial Pathogens
S Shaikh, SMD Rizvi, S Shakil, T Hussain, TM Alshammari, W Ahmad, ...Journal of cellular biochemistry 118 (9), 2802-2808, 2017201
45
2017
Recent updates on the association between Alzheimer’s disease and vascular dementia
G M Ashraf, S Chibber, S K Zaidi, S Tabrez, A Ahmad, S Shakil, ...Medicinal Chemistry 12 (3), 226-237, 2016201
42
2016
In silico screening of glycogen synthase kinase-3β targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer’s disease
NR Jabir, S Shakil, S Tabrez, MS Khan, MT Rehman, BA AhmedJournal of Biomolecular Structure and Dynamics 39 (14), 5083-5092, 2021202
27
2021
Molecular and enzoinformatics perspectives of targeting Polo-like kinase 1 in cancer therapy
S Shakil, MH Baig, S Tabrez, SMD Rizvi, SK Zaidi, GM Ashraf, SA Ansari, ...Seminars in Cancer Biology 56, 47-55, 2019201
27
2019
Genomic and antimicrobial resistance genes diversity in multidrug-resistant CTX-M-positive isolates of Escherichia coli at a health care facility in Jeddah
M Yasir, M Farman, MW Shah, AA Jiman-Fatani, NA Othman, ...Journal of Infection and Public Health 13 (1), 94-100, 2020202
26
2020
25
2017
A synopsis of nano-technological approaches toward anti-epilepsy therapy: present and future research implications
N R Jabir, S Tabrez, CK Firoz, S Kashif Zaidi, S S Baeesa, S Hua Gan, ...Current drug metabolism 16 (5), 336-345, 2015201
23
2015
22
2016
Current updates on therapeutic advances in the management of cardiovascular diseases
N R Jabir, A Nasir Siddiqui, C Kandy Firoz, G Md Ashraf, S Kashif Zaidi, ...Current Pharmaceutical Design 22 (5), 566-571, 161
20
2016
Estimation of Interleukin‐1β Promoter (− 31 C/T and− 511 T/C) Polymorphisms and Its Level in Coronary Artery Disease Patients
S Tabrez, NR Jabir, CK Firoz, S Hindawi, S Shakil, GA Damanhouri, ...Journal of Cellular Biochemistry 118 (9), 2977-2982, 2017201
19
2017
An insight towards anticancer potential of major coffee constituents
NR Jabir, MT Islam, S Tabrez, S Shakil, SK Zaidi, FR Khan, LS Araujo, ...BioFactors 44 (4), 315-326, 2018201
17
2018
Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer’s treatment
NR Jabir, MT Rehman, K Alsolami, S Shakil, TA Zughaibi, RF Alserihi, ...Annals of medicine 53 (1), 2332-2344, 2021202
17
2021
Nanobiotechnological approaches against multidrug resistant bacterial pathogens: An update
S Shaikh, S Shakil, A M Abuzenadah, P Michael Roberts, G Mushtaq, ...Current Drug Metabolism 16 (5), 362-370, 202
15
2015
Prevalence of CTX‐M resistance marker and integrons among Escherichia coli and Klebsiella pneumoniae isolates of clinical origin
S Shaikh, SMD Rizvi, R Anis, S ShakilLetters in Applied Microbiology 62 (5), 419-427, 2016201
14
2016